{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T22:03:35Z","timestamp":1743804215666},"reference-count":18,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,2,20]]},"DOI":"10.18632\/oncotarget.24392","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T13:31:27Z","timestamp":1517664687000},"page":"11638-11645","source":"Crossref","is-referenced-by-count":7,"title":["Long-term follow up of Hodgkin lymphoma"],"prefix":"10.18632","volume":"9","author":[{"given":"David","family":"Perez-Callejo","sequence":"first","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorea","family":"Zurutuza","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Royuela","sequence":"additional","affiliation":[{"name":"Statistics Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Torrente","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Calvo","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"M\u00e9ndez","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Franco","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Auxiliadora","family":"Brenes","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Cristobal","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Provencio","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,2,3]]},"reference":[{"key":"1","unstructured":"GLOBOCAN. 2012. Estimated cancer incidence, mortality and prevalence worldwide in 2012. Internacional Agency for Research on Cancer. 2012. http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_population.aspx (Accessed on May 10 2017)."},{"key":"2","unstructured":"Rueda. SEOM 2017. Linfoma de Hodgkin Marzo. 2017. http:\/\/www.seom.org\/es\/info-sobre-el-cancer\/linfoma-hodgkin?start=1 (Accessed on May 10 2017)."},{"key":"3","unstructured":"REDECAN (Red Espa\u00f1ola de Registros de C\u00e1ncer. Estimaciones de la incidencia y la supervivencia del c\u00e1ncer en Espa\u00f1a y su situaci\u00f3n en Europa. Octubre. 2014. http:\/\/redecan.org\/es\/page.cfm?id=196&title=estimaciones-de-la-incidencia-y-la-supervivencia-del-cancer-en-espana-y-su-situacion-en-europa (Accessed on May 10 2017)."},{"key":"4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/cam4.655","article-title":"Improved survival time trends in Hodgkin\u2019slymphoma","volume":"5","author":"Mahmood","year":"2016","journal-title":"Cancer Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.2016.70.9709","article-title":"Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History","volume":"35","author":"Hemminki","year":"2017","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1200\/JCO.2013.53.1194","article-title":"Treatment of Hodgkin lymphoma: a 50-year perspective","volume":"32","author":"Devita","year":"2014","journal-title":"J Clin Oncol"},{"key":"7","first-page":"366","article-title":"State-of-the-artissues in Hodgkin\u2019slymphomasurvivorship","volume":"12","author":"Matasar","year":"2010","journal-title":"Curr Oncol Rep"},{"key":"8","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin\u2019s disease","volume":"21","author":"van Leeuwen","year":"2003","journal-title":"J Clin Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1023\/A:1008306702211","article-title":"Comparison of the long-term mortality in Hodgkin\u2019s disease patients with that of the general population","volume":"10","author":"Espa\u00f1a","year":"1999","journal-title":"Ann Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S1470-2045(16)30093-6","article-title":"Cancer-related fatigue in patients with and survivors of Hodgkin\u2019s lymphoma: a longitudinal study of the German Hodgkin Study Group","volume":"17","author":"Fuchs","year":"2016","journal-title":"Lancet Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nm.2407","article-title":"Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin\u2019s lymphoma","volume":"17","author":"Mack","year":"2011","journal-title":"Nat Med"},{"key":"12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S1470-2045(16)30167-X","article-title":"Nivolumab for classical Hodgkin\u2019s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial","volume":"17","author":"Savage","year":"2016","journal-title":"Lancet Oncol"},{"key":"13","first-page":"1860","article-title":"Report of the Committee on Hodgkin\u2019s disease staging classification","volume":"31","author":"Tubiana","year":"1971","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: cotswolds meeting","volume":"7","author":"Tubiana","year":"1989","journal-title":"J Clin Oncol"},{"key":"15","first-page":"1268","article-title":"Extended field radical radiotherapy in advanced Hodgkin\u2019s disease","volume":"26","author":"Rosenberg","year":"1966","journal-title":"Cancer Res"},{"key":"16","first-page":"261","volume-title":"Modeling Survival Data Extending the Cox Model","author":"Grambsch","year":"2000"},{"key":"17","unstructured":"Breslow, Day. Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci Publ; pp. 1\u2013406. 1987."},{"key":"18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Therneau","year":"1994","journal-title":"Biometrika"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:02:04Z","timestamp":1589025724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,3]]},"references-count":18,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018,2,20]]}},"alternative-id":["24392","29545926"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24392","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,3]]}}}